Share Talk speak to #AMYT CEO Joe Wiley about their recent 'Transformational Licence Agreement' RNS of 5 Dec 2016. We also get some more background information about Amryt Pharma and their focus on best-in-class treatments for rare and orphan diseases.
Amryt Pharma, Joe Wiley CEO
Share Talk speak to #AMYT CEO Joe Wiley about their recent 'Transformational Licence Agreement' RNS of 5 Dec 2016. We also get some more background information about Amryt Pharma and their focus on best-in-class treatments for rare and orphan diseases.
